Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for selection of an ace inhibitor
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Drug target sets for approved compounds
- ER+ breast tumors with distinct clinical outcomes in untreated and endocrine-treated patients
- MCF7 tumor xenografts treated with BMS754807, Tamoxifen or Letrozole
Most Relevant Literature
- Impact of ACE inhibitors on mortality and morbidity in patients with AMI: Does tissue selectivity ma…
- Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting…
- Evaluation of efficacy and safety of hypertension treatment with original angiotensin-converting enz…
- Therapeutic melanoma inhibition by local micelle-mediated cyclic nucleotide repression.
- The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese.
Most Relevant Clinical Trials
- Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
- A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers
- Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
- CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Inter…
- Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor T…
